PRX-12266

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePRX-12266
Drug Alias NamePRX-12266
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine uptake inhibitorsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsMental DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPrexa Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPrexa Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMental DisordersNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A